Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
significantly improved from the previous year, and raised its full-year 2025 revenue and EBITDA guidance. This positive performance reflected broadening adoption of Artivion's stent grafts and heart valves, as well as momentum in clinical trials for the company's innovative Arcevo LSA device. Next, we'll consider how Artivion's updated outlook and strong product adoption influence its investment thesis and growth prospects. AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early. Artivion Investment Narrative Recap To be an Artivion shareholder, you need to believe in the company's ability to drive sustained growth through innovation, adoption of advanced aortic stent grafts and heart valves, and successful execution on its clinical pipeline. The strong third-quarter results and raised full-year guidance reinforce the curre
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]Yahoo! Finance
- 2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT): Is the Healthcare Standout Fairly Valued After Recent Surge? [Yahoo! Finance]Yahoo! Finance
- Artivion's (NYSE:AORT) Q3 Sales Top Estimates [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 11/6/25 - Beat
AORT
Sec Filings
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- 12/3/25 - Form 4
- AORT's page on the SEC website